PharmaCyte Biotech, Inc. (PMCB) today announced that it has successfully completed the comprehensive characterization of its proprietary cell clone known ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE